Sabbatini P - Search Results

1

Patient online self-reporting of toxicity symptoms during chemotherapy.

Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Basch E, et al. Among authors: sabbatini p. J Clin Oncol. 2005 May 20;23(15):3552-61. doi: 10.1200/JCO.2005.04.275. J Clin Oncol. 2005. PMID: 15908666

2

Chemotherapy in gynecologic cancer.

Sabbatini P, Aghajanian C, Spriggs D. Sabbatini P, et al. Curr Opin Oncol. 1998 Sep;10(5):429-33. doi: 10.1097/00001622-199809000-00010. Curr Opin Oncol. 1998. PMID: 9800113 Review.

3

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

Sabbatini P, Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C, Ouyang P, Kelly WK, Scher HI. Sabbatini P, et al. J Clin Oncol. 1999 Mar;17(3):948-57. doi: 10.1200/JCO.1999.17.3.948. J Clin Oncol. 1999. PMID: 10071289 Clinical Trial.

4

Implementation of disease management guidelines in patients with advanced ovarian cancer.

Hensley ML, Sabbatini P, Spriggs D. Hensley ML, et al. Among authors: sabbatini p. Semin Oncol. 1999 Feb;26(1 Suppl 1):46-51. Semin Oncol. 1999. PMID: 10071973 Review.

5

Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.

Husain A, Sabbatini P, Spriggs D, Fennelly D, Aghajanian C, Barakat R, Curtin J, Venkatraman E, Hoskins W, Markman M. Husain A, et al. Among authors: sabbatini p. Gynecol Oncol. 1999 Apr;73(1):96-101. doi: 10.1006/gyno.1998.5317. Gynecol Oncol. 1999. PMID: 10094887 Clinical Trial.

6

Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.

Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R. Makhija S, et al. Among authors: sabbatini p. Gynecol Oncol. 2000 Oct;79(1):28-32. doi: 10.1006/gyno.2000.5890. Gynecol Oncol. 2000. PMID: 11006026 Clinical Trial.

7

Complications associated with intraperitoneal chemotherapy catheters.

Makhija S, Leitao M, Sabbatini P, Bellin N, Almadrones L, Leon L, Spriggs DR, Barakat R. Makhija S, et al. Among authors: sabbatini p. Gynecol Oncol. 2001 Apr;81(1):77-81. doi: 10.1006/gyno.2000.6108. Gynecol Oncol. 2001. PMID: 11277654

8

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Hensley ML, et al. Among authors: sabbatini p. Gynecol Oncol. 2001 Jun;81(3):485-9. doi: 10.1006/gyno.2001.6185. Gynecol Oncol. 2001. PMID: 11371143

9

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. Hensley ML, et al. Among authors: sabbatini p. Gynecol Oncol. 2001 Sep;82(3):464-9. doi: 10.1006/gyno.2001.6299. Gynecol Oncol. 2001. PMID: 11520141

10

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D. Barakat RR, et al. Among authors: sabbatini p. J Clin Oncol. 2002 Feb 1;20(3):694-8. doi: 10.1200/JCO.2002.20.3.694. J Clin Oncol. 2002. PMID: 11821450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters